Suppr超能文献

分流电阻与诺伍德手术后临床上重要的结果相关。

Shunt resistance is associated with clinically important outcomes after the Norwood operation.

作者信息

Spigel Zachary A, Qureshi Athar M, Kalustian Alyssa, Binsalamah Ziyad M, Imamura Michiaki, Caldarone Christopher A

机构信息

Division of Congenital Heart Surgery, Department of Surgery, Baylor College of Medicine and Texas Children's Hospital, Houston, Tex.

Division of Cardiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Tex.

出版信息

JTCVS Open. 2022 Jan 22;9:206-214. doi: 10.1016/j.xjon.2022.01.006. eCollection 2022 Mar.

Abstract

BACKGROUND

In single-ventricle physiology, focus on pulmonary vascular resistance neglects the resistance in the conduit supplying the pulmonary inflow.

METHODS

Conduit length and diameter, which can approximate conduit resistance, are available in the public dataset of Single Ventricle Reconstruction (SVR) trial. Conduit resistance was then calculated for SVR trial participants and the relationship with clinically important variables (death or transplant at 1 year, pulmonary artery size at second-stage palliation, pulmonary-to-systemic blood flow ratio, and supplemental oxygen requirement) was explored. To validate this calculated resistance, calculated resistance was compared with catheterization measurements at a single institution (not included in the SVR trial).

RESULTS

In the institutional dataset, calculated and measured resistances had an intraclass correlation of 0.78 for modified Blalock-Taussig shunts (MBTS). Within the SVR trial, transplant-free survivors had a lower MBTS resistance (median, 8.3 Woods Units [WU]. interquartile range [IQR], 6.5-11.1 WU) than patients who died or required transplantation (median, 13.0 WU; IQR, 9.4-16.6 WU,  = .0001). When we controlled for left pulmonary artery diameter after the Norwood procedure in the SVR trial, for each unit increase in MBTS resistance, the left pulmonary artery diameter at stage II decreased (-0.006 ± 0.002 cm,  = .005). When we controlled for pulmonary vascular resistance, greater MBTS resistance was associated with a decrease in log pulmonary-to-systemic blood flow ratio (-0.04 ± 0.015,  = .0048) in the SVR trial. Patients in the SVR trial requiring supplemental oxygen on admission for stage II palliation had greater MBTS resistance (median. 11.1 WU; IQR, 6.6-16.6 WU) than patients not requiring oxygen (median 8.3, WU; IQR, 6.5-11.1 WU,  = .015).

CONCLUSIONS

Conduit resistance is associated with important clinical outcomes after Norwood; however, further studies are required to guide conduit resistance optimization.

摘要

背景

在单心室生理中,对肺血管阻力的关注忽略了供应肺血流的管道中的阻力。

方法

单心室重建(SVR)试验的公共数据集中提供了可近似管道阻力的管道长度和直径。然后计算了SVR试验参与者的管道阻力,并探讨了其与临床重要变量(1年时死亡或移植、二期姑息治疗时肺动脉大小、肺循环与体循环血流量之比以及补充氧气需求)之间的关系。为了验证这种计算出的阻力,将计算出的阻力与单个机构(不包括在SVR试验中)的导管测量值进行了比较。

结果

在机构数据集中,改良Blalock-Taussig分流术(MBTS)的计算阻力与测量阻力的组内相关系数为0.78。在SVR试验中,无移植存活者的MBTS阻力(中位数,8.3伍兹单位[WU],四分位间距[IQR],6.5 - 11.1 WU)低于死亡或需要移植的患者(中位数,13.0 WU;IQR,9.4 - 16.6 WU,P = 0.0001)。在SVR试验中,当我们对诺伍德手术后的左肺动脉直径进行控制时,MBTS阻力每增加一个单位,二期时左肺动脉直径减小(-0.006 ± 0.002 cm,P = 0.005)。在SVR试验中,当我们对肺血管阻力进行控制时,更高的MBTS阻力与肺循环与体循环血流量之比的对数降低相关(-0.04 ± 0.015,P = 0.0048)。在SVR试验中,二期姑息治疗入院时需要补充氧气的患者的MBTS阻力(中位数,11.1 WU;IQR,6.6 - 16.6 WU)高于不需要氧气的患者(中位数,8.3 WU;IQR,6.5 - 11.1 WU,P = 0.015)。

结论

诺伍德手术后,管道阻力与重要临床结局相关;然而,需要进一步研究以指导管道阻力的优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc23/9390403/1c6e31e73886/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验